This article presents a comparative study between traditional plasmid DNA vaccines and novel enzymatically produced linear DNA constructs known as “Doggybones.” These linear constructs, which exclude unnecessary bacterial elements, demonstrated equivalent gene expression and immune responses in preclinical models, offering a promising alternative for safer and scalable DNA vaccine production.

Download the full article to learn more about:

• How dbDNA™  (Doggybone) constructs eliminate unwanted bacterial elements to enhance vaccine safety.
• How these novel constructs perform comparably to plasmids in both gene expression and immune response.
• Explore the potential for large-scale, enzymatic production of DNA vaccines without the need for bacterial culture.